Effect of Gamma-cyclodextrin on the Bioavailability of Berberine

Clinical trial NCT04918667 · NOT_YET_RECRUITING

Trial details

NCT number: NCT04918667
Sponsor: EuroPharma, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Absorption

Start date: 2024-09-01
Primary completion: 2025-11-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.